Abstract:Members of the receptor protein tyrosine phosphatase (RPTP) subfamily of cell adhesion molecules (CAMs) mediate neurite outgrowth and growth cone repulsion. PTPmu is a growth permissive substrate for nasal retinal ganglion cell (RGC) neurites and a growth inhibitory substrate for temporal RGCs. In this manuscript, we demonstrate that the distinct PTPmu-dependent phenotypes of nasal outgrowth and temporal repulsion are regulated by Rho GTPases. The role of Rho GTPases in the regulation of nasal outgrowth and te… Show more
“…RhoA is involved in growth cone retraction and plays a central role in inhibition of axon outgrowth by myelin-derived inhibitors (Thies andDavenport 2003, Auer et al 2012). Rac1 and Cdc42 regulate neurite outgrowth and the growth cone morphology of most neurons (Oblander andBradyKalnay 2010, Major andBrady-Kalnay 2007). Accumulating evidence indicates that another key mechanism by which Rac and Cdc42 relay signals to the actin cytoskeleton involves the Wiskott-Aldrich syndrome family of scaffolding proteins (Millard et al 2004;Smith andLi 2004, Govek et al 2005).…”
Section: Role Of Gtpases In Neurite Outgrowthmentioning
Autism spectrum disorder is a heterogeneous disease, and numerous alterations of gene expression come into play to attempt to explain potential molecular and pathophysiological causes. Abnormalities of brain development and connectivity associated with alterations in cytoskeletal rearrangement, neuritogenesis and elongation of axons and dendrites might represent or contribute to the structural basis of autism pathology. Slit/Robo signaling regulates cytoskeletal remodeling related to axonal and dendritic branching. Components of its signaling pathway (ABL and Cdc42) are suspected to be molecular bases of alterations of normal development. The present review describes the most important mechanisms underlying neuritogenesis, axon pathfinding and the role of GTPases in neurite outgrowth, with special emphasis on alterations associated with autism spectrum disorders. On the basis of analysis of publicly available microarray data, potential biomarkers of autism are discussed.
“…RhoA is involved in growth cone retraction and plays a central role in inhibition of axon outgrowth by myelin-derived inhibitors (Thies andDavenport 2003, Auer et al 2012). Rac1 and Cdc42 regulate neurite outgrowth and the growth cone morphology of most neurons (Oblander andBradyKalnay 2010, Major andBrady-Kalnay 2007). Accumulating evidence indicates that another key mechanism by which Rac and Cdc42 relay signals to the actin cytoskeleton involves the Wiskott-Aldrich syndrome family of scaffolding proteins (Millard et al 2004;Smith andLi 2004, Govek et al 2005).…”
Section: Role Of Gtpases In Neurite Outgrowthmentioning
Autism spectrum disorder is a heterogeneous disease, and numerous alterations of gene expression come into play to attempt to explain potential molecular and pathophysiological causes. Abnormalities of brain development and connectivity associated with alterations in cytoskeletal rearrangement, neuritogenesis and elongation of axons and dendrites might represent or contribute to the structural basis of autism pathology. Slit/Robo signaling regulates cytoskeletal remodeling related to axonal and dendritic branching. Components of its signaling pathway (ABL and Cdc42) are suspected to be molecular bases of alterations of normal development. The present review describes the most important mechanisms underlying neuritogenesis, axon pathfinding and the role of GTPases in neurite outgrowth, with special emphasis on alterations associated with autism spectrum disorders. On the basis of analysis of publicly available microarray data, potential biomarkers of autism are discussed.
“…Rac1 and Cdc42 regulate neurite outgrowth and growth cone morphology of most neurons including on a PTPμ substrate (Major and Brady-Kalnay, 2007). In order to test a role for the Rho GTPases in cadherin-mediated neurite outgrowth, E8 chick retinal explants were infected with HSV encoding GFP control (Fig.…”
Section: Resultsmentioning
confidence: 99%
“…Cdc42, Rac1 and RhoA are expressed in the chick retina and are involved in PTPμ-mediated growth cone rearrangement and neurite outgrowth (Major and Brady-Kalnay, 2007; Rosdahl et al, 2003). PTPμ promotes neurite outgrowth from nasal RGCs but is repulsive to temporal RGCs (Burden-Gulley et al, 2002).…”
Section: Discussionmentioning
confidence: 99%
“…Cdc42 activity is required for PTPμ-mediated nasal outgrowth and temporal repulsion. Temporal repulsion of these neurites also requires inhibition of Rac1 activity (Major and Brady-Kalnay, 2007). We have also previously shown that IQGAP1 binds directly to PTPμ and that the IQGAP1/PTPμ association increases in the presence of activated Cdc42 (Phillips-Mason et al, 2006), which is required for PTPμ-mediated neurite outgrowth (Phillips-Mason et al, 2006).…”
Classical cadherins play distinct roles in axon growth and guidance in the visual system, however, the signaling pathways they activate remain unclear. Growth cones on each cadherin substrate have a unique morphology suggesting that distinct signals are activated by neurite outgrowth on E-, N-, and R-cadherin. We previously demonstrated that receptor protein tyrosine phosphatase-mu (PTPmu) is required for E-and N-cadherin-dependent neurite outgrowth. In this manuscript, we demonstrate that PTPmu regulates R-cadherin-mediated neurite outgrowth. Furthermore, we evaluated whether known PTPmu-associated signaling proteins, Rac1, Cdc42, IQGAP1 and PKCδ, regulate neurite outgrowth mediated by these cadherins. While Rac1 activity is required for neurite outgrowth on all three cadherins, Cdc42/IQGAP1 are required only for N-and R-cadherin-mediated neurite outgrowth. In addition, we determined that PKC activity is required for E-and R-cadherinmediated, but not N-cadherin-mediated neurite outgrowth. In summary, distinct PTPμ-associated signaling proteins are required to promote neurite outgrowth on cadherins.
“…Tyrosine phosphatase activity of PTPμ is necessary for
its regulation of neurite outgrowth [42]. Neurite outgrowth on a purified PTPμ substrate requires
signaling via PLCγ1, PKCδ, the Rho GTPases Cdc42 and Rac1, and IQGAP1
[43–48]. …”
The initial cloning of receptor protein tyrosine phosphatases (RPTPs) was met
with excitement because of their hypothesized function in counterbalancing receptor
tyrosine kinase signaling. In recent years, members of a subfamily of RPTPs with
homophilic cell-cell adhesion capabilities, known as the R2B subfamily, have been shown to
have functions beyond that of counteracting tyrosine kinase activity, by independently
influencing cell signaling in their own right and by regulating cell adhesion. The R2B
subfamily is composed of four members: PTPmu (PTPRM), PTPrho (PTPRT), PTPkappa (PTPRK),
and PCP-2 (PTPRU). The effects of this small subfamily of RPTPs is far reaching,
influencing several developmental processes and cancer. In fact, R2B RPTPs are predicted
to be tumor suppressors and are among the most frequently mutated protein tyrosine
phosphatases (PTPs) in cancer. Confounding these conclusions are more recent studies
suggesting that proteolysis of the full-length R2B RPTPs result in oncogenic extracellular
and intracellular protein fragments. This review discusses the current knowledge of the
role of R2B RPTPs in development and cancer, with special detail given to the mechanisms
and implications that proteolysis has on R2B RPTP function. We also touch upon the concept
of exploiting R2B proteolysis to develop cancer imaging tools, and consider the effects of
R2B proteolysis on axon guidance, perineural invasion and collective cell migration.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.